Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185107 · ClinicalTrials.gov registry record · Phase 4
Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol
A Phase 4 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT00185107: Completed Phase 4 study, sponsored by Daiichi Sankyo.
NCT00185107 is a Phase 4 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 45 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185107, a Phase 4 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
Assess the efficacy of WelChol® plus Zetia® in treating patients with high cholesterol
Interventions
- DRUG Simvastatin
- DRUG Ezetimibe
- DRUG Colesevelam Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2005-03 |
| Est. Completion | 2005-10 |
| Phase | Phase 4 |
What the finished NCT00185107 record still lists
NCT00185107 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 3 interventions - of which Simvastatin is the first listed.
NCT00185107 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00185107 about?
NCT00185107 is a clinical study titled "Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol". Assess the efficacy of WelChol® plus Zetia® in treating patients with high cholesterol
What is the current status of trial NCT00185107?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2005-03. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00185107?
The interventions under investigation include: Simvastatin (DRUG), Ezetimibe (DRUG), Colesevelam Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00185107?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00185107's enrollment target sits among peer trials
45 1354th of 2000 higher than 638 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia